Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase Ib/II trial of Ibrutinib and Nivolumab in Patients with Advanced Refractory Renal Cell Carcinoma.AuthorsParikh, Mamta; Tenold, Matthew E.; Lihong Qi; Lara, Frances; Robles, Daniel; Meyers, Frederick J.; Lara, Primo N.PublicationKidney Cancer (2468-4562), 2021, Vol 5, Issue 4, p181ISSN2468-4562Publication typeArticleDOI10.3233/KCA-210128